Fabien Collangettes

Fabien Collangettes is a Partner at Omnes Capital and a board member for several organizations, including SeqOne Genomics, Capsule Corp. Labs, and Therapixel. Previously, they served as a board member at Themis Bioscience GmbH, which was acquired by Group MSD, and Sentryo, which was acquired by Cisco. Fabien co-founded Tribway, which was later acquired by CIS Valley, and they have held various roles in finance and strategic advisory since obtaining a Master of Science in Finance from Imperial College London. Currently, they also act as a board observer for Iktos and Qubit Pharmaceuticals.